Potential binding sites containing eight residues derived from binding site similarity searches
DrReposER ID
Hit
Organism / Macromolecule
Interface
HETATM
RMSD
Dali Z-score
Seq. Identity (%)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
SER A 148THR A 150ASN A 152CYH A 153HIS A 176TYR A 312ASN A 314TYR A 318
OCS A 149 ( 3.5A)OCS A 149 ( 3.8A)NoneNoneOCS A 149 ( 4.0A)OCS A 149 ( 4.1A)NAD A 401 (-3.7A)NAD A 401 (-3.5A)
0.33A
1dssR-5ur0A:51.4
1dssR-5ur0A:undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
SER A 155THR A 157ASN A 159CYH A 160HIS A 183TYR A 318ASN A 320TYR A 324
NoneNoneNoneNoneNoneNoneNAD A 401 (-3.7A)NAD A 401 (-3.6A)
0.43A
1dssR-5y37A:47.2
1dssR-5y37A:undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
SER A 150THR A 152ASN A 154CYH A 155HIS A 178TYR A 313ASN A 315TYR A 319
PO4 A 402 (-2.7A)PO4 A 402 (-3.1A)NoneNonePO4 A 402 (-4.0A)NoneNAD A 401 (-4.0A)NAD A 401 (-3.6A)
0.21A
1dssR-6dfzA:54.4
1dssR-6dfzA:undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
ILE B 67LEU B 72MET B 91ILE B 92GLU B 94VAL B 95ILE B 103MET B 111
None
0.75A
1linA-2jjzB:8.8
1linA-2jjzB:22.29
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
TRP A 245GLY A 279TYR A 282GLU A 359SER A 360TRP A 441TYR A 493HIS A 600
None
0.60A
1maaD-6arxA:55.1
1maaD-6arxA:9.77
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
HIS A 163HIS A 165HIS A 182VAL A 184VAL A 201LEU A 259THR A 260TRP A 270
ZN A 378 (-3.2A) ZN A 378 (-3.3A) ZN A 378 (-3.1A)NoneNoneNone ZN A 378 ( 4.5A)None
0.36A
2gehA-3b1bA:25.2
2gehA-3b1bA:25.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
HIS A 117HIS A 119HIS A 136VAL A 138VAL A 148LEU A 201THR A 202TRP A 212
ZN A 301 (-3.3A) ZN A 301 (-3.3A) ZN A 301 (-3.2A)NoneNoneNone ZN A 301 (-4.4A)None
0.29A
2gehA-6ekiA:29.8
2gehA-6ekiA:16.60
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
HIS A 94HIS A 96HIS A 119VAL A 121VAL A 143LEU A 198THR A 199TRP A 209
ZN A 301 ( 3.2A) ZN A 301 ( 3.2A) ZN A 301 ( 3.1A)V14 A 302 (-4.7A)NoneV14 A 302 (-3.6A)V14 A 302 (-3.2A)None
0.34A
2gehA-6fe1A:33.8
2gehA-6fe1A:14.90
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
TRP A 245TYR A 282TYR A 291GLU A 359TYR A 489PHE A 490HIS A 600GLY A 601
SEB A 360 ( 4.2A)NoneNoneSEB A 360 ( 3.3A)NoneNoneSEB A 360 ( 4.2A)None
0.38A
2ha4A-5ydjA:59.7
2ha4A-5ydjA:undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
TRP A 245TYR A 282TYR A 291GLU A 359TYR A 489PHE A 490HIS A 600GLY A 601
None
0.43A
2ha4A-6arxA:57.2
2ha4A-6arxA:undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
HIS A 131HIS A 132PHE A 141ASP A 168HIS A 170PHE A 198ASP A 258GLY A 295
TSN A 502 (-4.0A)TSN A 502 (-3.9A)TSN A 502 (-3.7A) ZN A 501 ( 2.3A) ZN A 501 ( 3.1A)TSN A 502 ( 3.9A) ZN A 501 ( 2.5A) ZN A 501 ( 4.1A)
0.41A
3c0zB-1c3rA:39.3
3c0zB-1c3rA:24.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
HIS A 145HIS A 146PHE A 155ASP A 181HIS A 183PHE A 210ASP A 269GLY A 306
LLX A 400 (-4.0A)LLX A 400 (-3.8A)LLX A 400 (-4.1A) ZN A 379 (-2.3A) ZN A 379 (-3.2A)LLX A 400 (-3.6A) ZN A 379 ( 2.5A)LLX A 400 (-3.7A)
0.37A
3c0zB-3maxA:42.1
3c0zB-3maxA:25.35
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
HIS A 134HIS A 135PHE A 144ASP A 170HIS A 172PHE A 200ASP A 259GLY A 296
ACT A 501 (-4.0A)ACT A 501 (-3.7A)None ZN A 500 (-2.2A) ZN A 500 (-3.1A)None ZN A 500 ( 2.4A)ACT A 501 (-3.0A)
0.38A
3c0zB-4a69A:41.3
3c0zB-4a69A:24.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
HIS B 140HIS B 141PHE B 150ASP B 176HIS B 178PHE B 205ASP B 264GLY B 301
ACT B 601 (-3.7A)ACT B 601 (-3.8A)None ZN B 600 (-2.2A) ZN B 600 (-3.3A)None ZN B 600 ( 2.5A)ACT B 601 (-3.4A)
0.37A
3c0zB-4bkxB:41.5
3c0zB-4bkxB:23.43
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
HIS A 141HIS A 142PHE A 151ASP A 186HIS A 188PHE A 216ASP A 285GLY A 339
B3N A 700 (-3.9A)B3N A 700 (-3.7A)B3N A 700 (-4.2A) ZN A 500 (-2.3A) ZN A 500 (-3.1A)B3N A 700 ( 3.7A) ZN A 500 ( 2.5A)B3N A 700 ( 4.1A)
0.35A
3c0zB-4bz7A:38.7
3c0zB-4bz7A:25.40
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
HIS A 142HIS A 143PHE A 152ASP A 178HIS A 180PHE A 208ASP A 267GLY A 304
NoneEDO A 410 (-4.4A)EDO A 407 (-4.2A) ZN A 401 ( 2.3A) ZN A 401 ( 3.1A)EDO A 410 ( 3.7A) ZN A 401 (-2.4A) ZN A 401 ( 4.2A)
0.39A
3c0zB-5vi6A:40.1
3c0zB-5vi6A:25.73
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
SER A 148THR A 150ASN A 152CYH A 153HIS A 176TYR A 312ASN A 314TYR A 318
OCS A 149 ( 3.5A)OCS A 149 ( 3.8A)NoneNoneOCS A 149 ( 4.0A)OCS A 149 ( 4.1A)NAD A 401 (-3.7A)NAD A 401 (-3.5A)
0.24A
3dmtC-5ur0A:49.7
3dmtC-5ur0A:undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
SER A 155THR A 157ASN A 159CYH A 160HIS A 183TYR A 318ASN A 320TYR A 324
NoneNoneNoneNoneNoneNoneNAD A 401 (-3.7A)NAD A 401 (-3.6A)
0.36A
3dmtC-5y37A:46.7
3dmtC-5y37A:undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
SER A 150THR A 152ASN A 154CYH A 155HIS A 178TYR A 313ASN A 315TYR A 319
PO4 A 402 (-2.7A)PO4 A 402 (-3.1A)NoneNonePO4 A 402 (-4.0A)NoneNAD A 401 (-4.0A)NAD A 401 (-3.6A)
0.23A
3dmtC-6dfzA:27.4
3dmtC-6dfzA:undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
GLY A 9VAL A 42HIS A 45ASP A 135ILE A 136VAL A 144VAL A 146GLN A 150
TRP A 501 (-3.5A)TRP A 501 ( 4.6A)TRP A 501 (-4.0A)TRP A 501 (-3.9A)NoneNoneNoneTRP A 501 (-3.3A)
0.55A
3fi0B-6dfuA:38.5
3fi0B-6dfuA:undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
GLY A 9VAL A 42HIS A 45ASP A 135ILE A 136VAL A 144VAL A 146GLN A 150
TRP A 501 (-3.5A)TRP A 501 ( 4.6A)TRP A 501 (-4.0A)TRP A 501 (-3.9A)NoneNoneNoneTRP A 501 (-3.3A)
0.62A
3fi0G-6dfuA:40.1
3fi0G-6dfuA:undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
GLY A 9GLN A 11VAL A 42HIS A 45ASP A 135ILE A 136VAL A 144VAL A 146
TRP A 501 (-3.5A)TRP A 501 (-4.2A)TRP A 501 ( 4.6A)TRP A 501 (-4.0A)TRP A 501 (-3.9A)NoneNoneNone
0.74A
3fi0Q-6dfuA:39.8
3fi0Q-6dfuA:undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
TRP A 81PRO A 82VAL A 87LEU A 92LEU A 94ASN A 140ILE A 146MET A 149
NoneH1V A 501 (-4.6A)H1V A 501 ( 4.4A)H1V A 501 (-4.2A)H1V A 501 (-4.7A)H1V A 501 (-3.2A)H1V A 501 (-3.8A)H1V A 501 ( 3.8A)
0.36A
3u5kA-6dneA:24.0
3u5kA-6dneA:undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
TRP A 81PRO A 82VAL A 87LEU A 92LEU A 94ASN A 140ILE A 146MET A 149
NoneH1V A 501 (-4.6A)H1V A 501 ( 4.4A)H1V A 501 (-4.2A)H1V A 501 (-4.7A)H1V A 501 (-3.2A)H1V A 501 (-3.8A)H1V A 501 ( 3.8A)
0.45A
3u5kC-6dneA:23.5
3u5kC-6dneA:undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
TRP A 81PRO A 82VAL A 87LEU A 92LEU A 94ASN A 140ILE A 146MET A 149
NoneH1V A 501 (-4.6A)H1V A 501 ( 4.4A)H1V A 501 (-4.2A)H1V A 501 (-4.7A)H1V A 501 (-3.2A)H1V A 501 (-3.8A)H1V A 501 ( 3.8A)
0.50A
3u5kD-6dneA:23.4
3u5kD-6dneA:undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
TYR A 44PHE A 65VAL A 74ILE A 75TRP A 78TYR A 101ILE A 110PHE A 118
FK5 A 501 (-4.1A)FK5 A 501 (-4.1A)FK5 A 501 (-3.5A)FK5 A 501 (-4.3A)FK5 A 501 (-3.3A)FK5 A 501 (-4.7A)NoneFK5 A 501 (-4.8A)
0.27A
3uqbA-2vn1A:19.8
3uqbA-2vn1A:28.57
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
TYR A 57PHE A 77VAL A 86ILE A 87TRP A 90TYR A 113ILE A 122PHE A 130
None
0.65A
3uqbA-3o5dA:15.7
3uqbA-3o5dA:25.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
TYR A 43PHE A 64VAL A 73ILE A 74TRP A 77TYR A 100ILE A 109PHE A 117
None
0.43A
3uqbA-3pa7A:19.5
3uqbA-3pa7A:28.17
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
TYR A 57PHE A 77VAL A 86ILE A 87TRP A 90TYR A 113ILE A 122PHE A 130
NoneNoneDMS A 304 (-3.5A)DMS A 304 (-3.8A)DMS A 304 ( 4.0A)NoneNoneDMS A 304 (-4.3A)
0.56A
3uqbA-4lawA:19.1
3uqbA-4lawA:24.40
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
TYR C 36PHE C 64VAL C 73ILE C 74TRP C 77TYR C 100ILE C 109PHE C 117
FK5 C 201 (-4.1A)FK5 C 201 (-3.8A)FK5 C 201 (-3.5A)FK5 C 201 (-3.8A)FK5 C 201 (-3.4A)FK5 C 201 (-4.5A)NoneFK5 C 201 (-4.7A)
0.25A
3uqbA-5b8iC:18.0
3uqbA-5b8iC:28.23
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
TYR A 30PHE A 50VAL A 59ILE A 60TRP A 63TYR A 97ILE A 106PHE A 114
None
0.40A
3uqbA-5i98A:18.1
3uqbA-5i98A:29.52
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
VAL A 67TRP A 87HIS A 118ASP A 120HIS A 196CYH A 221ASN A 233HIS A 263
NoneNoneGOL A 1 (-3.4A) ZN A 2 ( 2.4A)GOL A 1 (-3.5A) ZN A 2 ( 2.2A)GOL A 1 (-3.4A) ZN A 2 ( 3.3A)
0.54A
4exsB-3q6vA:8.2
4exsB-3q6vA:22.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
HIS A 862GLY A 863TYR A 896ALA A 898LYS A 903SER A 904TYR A 907GLU A 988
BZC A 201 (-4.0A)BZC A 201 (-3.9A)BZC A 201 (-4.0A)BZC A 201 ( 3.9A)BZC A 201 ( 4.8A)BZC A 201 (-3.3A)BZC A 201 (-3.6A)BZC A 201 (-4.0A)
0.86A
4hyfB-1efyA:20.0
4hyfB-1efyA:23.42
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
HIS A 384GLY A 385TYR A 414ALA A 416LYS A 421SER A 422TYR A 425GLU A 514
KU8 A 601 (-4.0A)KU8 A 601 (-3.5A)KU8 A 601 (-4.1A)KU8 A 601 ( 4.0A)KU8 A 601 (-4.3A)KU8 A 601 (-2.9A)KU8 A 601 (-3.5A)KU8 A 601 (-3.9A)
0.76A
4hyfB-3c49A:19.6
4hyfB-3c49A:23.24
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
HIS A 862GLY A 863TYR A 896ALA A 898LYS A 903SER A 904TYR A 907GLU A 988
BZC A 201 (-4.0A)BZC A 201 (-3.9A)BZC A 201 (-4.0A)BZC A 201 ( 3.9A)BZC A 201 ( 4.8A)BZC A 201 (-3.3A)BZC A 201 (-3.6A)BZC A 201 (-4.0A)
0.53A
4hyfC-1efyA:20.0
4hyfC-1efyA:23.42
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
HIS A 201GLY A 202TYR A 235ALA A 237LYS A 242SER A 243TYR A 246GLU A 327
8E6 A 401 (-3.5A)8E6 A 401 (-3.9A)8E6 A 401 (-4.1A)8E6 A 401 (-3.5A)8E6 A 401 (-4.3A)8E6 A 401 (-2.6A)8E6 A 401 (-3.4A)8E6 A 401 (-3.9A)
0.56A
4hyfC-5xstA:20.3
4hyfC-5xstA:undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
GLY A 189GLN A 190TYR A 193SER A 208PHE A 209SER A 220ASN A 255HIS A 318
None
0.85A
4wryA-5x55A:26.6
4wryA-5x55A:21.84
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
GLY A 189GLN A 190TYR A 193SER A 208PHE A 209SER A 220ASN A 255HIS A 318
None
0.94A
4wrzA-5x55A:26.3
4wrzA-5x55A:21.84
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
VAL A 67TRP A 87HIS A 118ASP A 120HIS A 196CYH A 221ASN A 233HIS A 263
NoneNoneGOL A 1 (-3.4A) ZN A 2 ( 2.4A)GOL A 1 (-3.5A) ZN A 2 ( 2.2A)GOL A 1 (-3.4A) ZN A 2 ( 3.3A)
0.50A
5a5zA-3q6vA:27.1
5a5zA-3q6vA:23.83
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
PHE A 51GLY A 96TRP A 97GLU A 144TYR A 214ASP A 215ARG A 294TRP A 403
NGO A 502 (-4.7A)NGO A 502 ( 3.8A)NAG A 503 ( 3.7A)NGO A 502 (-3.4A)NGO A 502 (-4.5A)NGO A 502 ( 3.1A)NAG A 503 ( 4.9A)NGO A 502 (-3.5A)
0.42A
5gqbA-1e6zA:34.8
5gqbA-1e6zA:23.92
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
PHE A 55GLY A 135TRP A 136GLU A 192TYR A 271ASP A 272ARG A 330TRP A 412
NoneNoneNoneGOL A 530 (-3.9A)GOL A 530 (-4.8A)GOL A 530 (-3.7A)NoneNone
0.32A
5gqbA-1kfwA:41.3
5gqbA-1kfwA:26.51
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
PHE A 58GLY A 98TRP A 99GLU A 140TYR A 212ASP A 213ARG A 269TRP A 360
None
0.48A
5gqbA-1wb0A:44.2
5gqbA-1wb0A:20.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
PHE A 38GLY A 98TRP A 99GLU A 139TYR A 207ASP A 208ARG A 263TRP A 346
None
0.66A
5gqbA-1wnoA:43.3
5gqbA-1wnoA:24.19
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
PHE A 74GLY A 133TRP A 134GLU A 174TYR A 242ASP A 243ARG A 298TRP A 381
None
0.65A
5gqbA-3g6lA:43.8
5gqbA-3g6lA:25.95
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
PHE A 58GLY A 113TRP A 114GLU A 153TYR A 222ASP A 223ARG A 278TRP A 395
None
0.51A
5gqbA-3qokA:36.8
5gqbA-3qokA:24.62
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
PHE A 61GLY A 106TRP A 107GLU A 148TYR A 217ASP A 218ARG A 274TRP A 372
None
0.54A
5gqbA-3w4rA:43.0
5gqbA-3w4rA:22.56
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
PHE A 61GLY A 106TRP A 107GLU A 148TYR A 217ASP A 218ARG A 274TRP A 372
NAG A 501 (-4.5A)NAG A 501 (-3.6A)NAG A 505 ( 3.4A)NAG A 501 (-2.7A)NAG A 501 (-4.6A)NAG A 501 ( 3.2A)NAG A 505 ( 3.6A)NAG A 501 (-3.7A)
0.52A
5gqbA-3wl1A:43.0
5gqbA-3wl1A:24.03
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
PHE A 58GLY A 113TRP A 114GLU A 153TYR A 222ASP A 223ARG A 278TRP A 395
NoneACT A 502 ( 4.6A)NoneACT A 502 (-3.8A)GOL A 504 ( 4.6A)GOL A 504 (-2.7A)GOL A 504 (-4.1A)GOL A 504 (-3.7A)
0.51A
5gqbA-4q22A:36.9
5gqbA-4q22A:25.52
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
PHE A 190GLY A 254TRP A 255GLU A 314TYR A 397ASP A 398ARG A 466TRP A 603
NoneNoneNone CS A 803 (-2.9A) CS A 812 (-4.4A) CS A 812 (-4.0A)None CS A 812 ( 4.2A)
0.60A
5gqbA-4txgA:32.5
5gqbA-4txgA:24.76
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
PHE B 78GLY B 141TRP B 142GLU B 183TYR B 250ASP B 251ARG B 307TRP B 388
NoneNoneMLI B 501 ( 3.8A)NoneNoneMLI B 501 ( 4.7A)NoneNone
0.67A
5gqbA-4w5uB:45.4
5gqbA-4w5uB:29.41
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
PHE B 590GLY B 651TRP B 652GLU B 691TYR B 766ASP B 767ARG B 818TRP B 905
None
0.53A
5gqbA-5gztB:41.7
5gqbA-5gztB:20.14
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
PHE A 590GLY A 651TRP A 652GLU A 691TYR A 766ASP A 767ARG A 818TRP A 905
None
0.63A
5gqbA-5gzuA:43.2
5gqbA-5gzuA:23.89
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
PHE A 191GLY A 274TRP A 275GLU A 315TYR A 392ASP A 393ARG A 448TRP A 541
GOL A 706 (-4.9A)GOL A 706 ( 4.1A)NoneGOL A 706 (-3.3A)GOL A 706 (-4.8A)GOL A 703 (-3.0A)GOL A 703 (-4.0A)GOL A 706 ( 3.8A)
0.30A
5gqbA-5zl9A:64.5
5gqbA-5zl9A:24.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
HIS A 94HIS A 96HIS A 119VAL A 121VAL A 143LEU A 198THR A 199TRP A 209
ZN A 901 ( 3.2A) ZN A 901 ( 3.2A) ZN A 901 ( 3.1A)AZM A1400 (-4.6A)AZM A1400 ( 4.9A)AZM A1400 (-3.9A)AZM A1400 (-3.6A)None
0.44A
5tt3F-1jd0A:25.1
5tt3F-1jd0A:29.09
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
HIS A 94HIS A 96HIS A 119VAL A 121VAL A 143LEU A 198THR A 199TRP A 209
ZN A 601 ( 3.3A) ZN A 601 (-3.3A) ZN A 601 ( 3.2A)AZM A 400 (-4.8A)NoneAZM A 400 (-3.7A)AZM A 400 (-3.6A)None
0.48A
5tt3F-1rj6A:25.1
5tt3F-1rj6A:28.83
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
HIS A 94HIS A 96HIS A 119VAL A 121VAL A 143LEU A 198THR A 199TRP A 209
ZN A 280 (-3.2A) ZN A 280 (-3.2A) ZN A 280 (-3.2A)NoneNoneNone ZN A 280 ( 4.9A)None
0.52A
5tt3F-1urtA:22.2
5tt3F-1urtA:26.88
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
HIS A 115HIS A 117HIS A 135VAL A 137VAL A 153LEU A 216THR A 217TRP A 227
ZN A 283 ( 3.2A) ZN A 283 (-3.2A) ZN A 283 ( 3.1A)ACY A 279 ( 4.7A)NoneACY A 279 (-4.3A)ACY A 279 (-3.4A)None
0.49A
5tt3F-1y7wA:22.9
5tt3F-1y7wA:23.43
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
HIS A 163HIS A 165HIS A 182VAL A 184VAL A 201LEU A 259THR A 260TRP A 270
ZN A 378 (-3.2A) ZN A 378 (-3.3A) ZN A 378 (-3.1A)NoneNoneNone ZN A 378 ( 4.5A)None
0.49A
5tt3F-3b1bA:24.4
5tt3F-3b1bA:25.46
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
HIS A 95HIS A 97HIS A 120VAL A 122VAL A 144LEU A 199THR A 200TRP A 210
ZN A 301 ( 3.6A) ZN A 301 ( 3.5A) ZN A 301 ( 3.2A)4MD A 401 ( 4.6A)4MD A 401 ( 4.4A)4MD A 401 (-4.2A)4MD A 401 (-3.2A)None
0.48A
5tt3F-3da2A:25.6
5tt3F-3da2A:28.47
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
HIS A 94HIS A 96HIS A 119VAL A 121VAL A 143LEU A 198THR A 199TRP A 209
ZN A 263 ( 3.2A) ZN A 263 ( 3.2A) ZN A 263 ( 3.1A)AZM A 264 (-4.7A)AZM A 264 ( 4.9A)AZM A 264 (-3.4A)AZM A 264 (-3.4A)None
0.38A
5tt3F-3ml5A:25.5
5tt3F-3ml5A:28.67
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
HIS A 123HIS A 125HIS A 142VAL A 144VAL A 154LEU A 214THR A 215TRP A 225
ZN A 1 ( 3.2A) ZN A 1 (-3.3A) ZN A 1 ( 3.2A)NoneMLT A 3 (-4.6A)MLT A 3 ( 4.2A)MLT A 3 ( 4.3A)MLT A 3 (-4.9A)
0.54A
5tt3F-3q31A:25.5
5tt3F-3q31A:29.17
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
HIS A 94HIS A 96HIS A 119VAL A 121VAL A 143LEU A 198THR A 199TRP A 209
ZN A 301 (-3.2A) ZN A 301 ( 3.2A) ZN A 301 ( 3.1A)520 A 302 ( 4.9A)520 A 302 ( 4.9A)520 A 302 (-3.6A)520 A 302 (-3.4A)None
0.50A
5tt3F-5cjfA:24.9
5tt3F-5cjfA:28.37
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
HIS X 93HIS X 95HIS X 118VAL X 120VAL X 141LEU X 196THR X 197TRP X 207
ZN X 301 (-3.2A) ZN X 301 (-3.2A) ZN X 301 (-3.1A)NoneNoneNone ZN X 301 ( 4.4A)None
0.42A
5tt3F-5eztX:25.5
5tt3F-5eztX:28.11
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
HIS A 94HIS A 96HIS A 119VAL A 121VAL A 143LEU A 198THR A 199TRP A 209
ZN A 301 ( 3.3A) ZN A 301 ( 3.3A) ZN A 301 ( 3.2A)EZL A 302 (-4.7A)EZL A 302 ( 4.7A)EZL A 302 (-3.5A)EZL A 302 (-3.4A)None
0.42A
5tt3F-5jn9A:24.0
5tt3F-5jn9A:28.26
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
HIS A 117HIS A 119HIS A 136VAL A 138VAL A 148LEU A 201THR A 202TRP A 212
ZN A 301 (-3.3A) ZN A 301 (-3.3A) ZN A 301 (-3.2A)NoneNoneNone ZN A 301 (-4.4A)None
0.42A
5tt3F-6ekiA:29.7
5tt3F-6ekiA:17.03
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
HIS A 94HIS A 96HIS A 119VAL A 121VAL A 143LEU A 198THR A 199TRP A 209
ZN A 301 ( 3.2A) ZN A 301 ( 3.2A) ZN A 301 ( 3.1A)V14 A 302 (-4.7A)NoneV14 A 302 (-3.6A)V14 A 302 (-3.2A)None
0.45A
5tt3F-6fe1A:24.6
5tt3F-6fe1A:21.29
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
THR A 37TRP A 116HIS A 191ASN A 194TYR A 196PHE A 250PRO A 295TYR A 375
HBA A 402 ( 3.9A)HBA A 402 ( 4.8A)FMN A 401 ( 3.5A)HBA A 402 ( 3.7A)HBA A 402 (-4.2A)HBA A 402 ( 4.8A)NoneHBA A 402 ( 4.4A)
0.16A
5v4vA-5v4pA:75.5
5v4vA-5v4pA:undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
THR A 37TRP A 116HIS A 191ASN A 194TYR A 196PHE A 250PRO A 295TYR A 375
HBA A 402 ( 3.9A)HBA A 402 ( 4.8A)FMN A 401 ( 3.5A)HBA A 402 ( 3.7A)HBA A 402 (-4.2A)HBA A 402 ( 4.8A)NoneHBA A 402 ( 4.4A)
0.17A
5v4vB-5v4pA:75.4
5v4vB-5v4pA:undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
GLY A 88TRP A 101ARG A 102GLN A 105TRP A 125VAL A 159ASP A 163TYR A 166
MGR A 300 ( 2.9A)MGR A 300 (-3.6A)MGR A 300 (-4.3A)MGR A 300 ( 3.0A)MGR A 300 (-3.5A)MGR A 300 (-4.4A)MGR A 300 (-3.5A)MGR A 300 (-3.0A)
0.37A
5vlmA-5vlgA:30.0
5vlmA-5vlgA:undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
GLY A 88TRP A 101ARG A 102GLN A 105TYR A 118TRP A 125ASP A 163ASP A 175
MGR A 300 ( 2.9A)MGR A 300 (-3.6A)MGR A 300 (-4.3A)MGR A 300 ( 3.0A)NoneMGR A 300 (-3.5A)MGR A 300 (-3.5A)MGR A 300 ( 4.3A)
0.39A
5vlmB-5vlgA:29.7
5vlmB-5vlgA:undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
ILE A 98TRP A 101ARG A 102GLN A 105TYR A 118TRP A 125VAL A 159ASP A 175
MGR A 300 (-3.1A)MGR A 300 (-3.6A)MGR A 300 (-4.3A)MGR A 300 ( 3.0A)NoneMGR A 300 (-3.5A)MGR A 300 (-4.4A)MGR A 300 ( 4.3A)
0.48A
5vlmF-5vlgA:29.2
5vlmF-5vlgA:undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
PRO A 82VAL A 87LEU A 92LEU A 94CYH A 136TYR A 139ASN A 140ILE A 146
H1V A 501 (-4.6A)H1V A 501 ( 4.4A)H1V A 501 (-4.2A)H1V A 501 (-4.7A)H1V A 501 ( 4.2A)NoneH1V A 501 (-3.2A)H1V A 501 (-3.8A)
0.46A
5y1yA-6dneA:23.4
5y1yA-6dneA:undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
MET A 295LEU A 298GLU A 305LEU A 339MET A 340ARG A 346HIS A 475LEU A 476
EST A 601 ( 4.4A)EST A 601 (-4.1A)EST A 601 (-2.4A)EST A 601 (-3.9A)EST A 601 ( 4.8A)EST A 601 (-4.1A)EST A 601 (-4.4A)EST A 601 (-3.5A)
0.34A
6cbzA-5toaA:31.6
6cbzA-5toaA:28.74
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
HIS A 34PRO A 35ASP A 187LYS A 189SER A 214SER A 255PHE A 258ASP A 266
SAM A 500 ( 3.8A)SAM A 500 (-4.3A)SAM A 500 (-2.8A)3PO A 501 ( 2.7A)SAM A 500 ( 4.0A)SAM A 500 (-2.7A)SAM A 500 (-3.5A)SAM A 500 (-3.3A)
0.23A
6fboA-4odjA:60.4
6fboA-4odjA:12.32
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
HIS A 34PRO A 35ASP A 187LYS A 189SER A 214SER A 255PHE A 258ASP A 266
SAM A 500 ( 3.8A)SAM A 500 (-4.3A)SAM A 500 (-2.8A)3PO A 501 ( 2.7A)SAM A 500 ( 4.0A)SAM A 500 (-2.7A)SAM A 500 (-3.5A)SAM A 500 (-3.3A)
0.23A
6fcdA-4odjA:60.0
6fcdA-4odjA:12.32
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
TYR D 58ASN D 60PHE D 77PHE C 99HIS C 101VAL C 202SER C 204TYR C 209
None
0.61A
6huoC-6dw1D:29.76huoD-6dw1D:29.0
6huoC-6dw1D:undetectable6huoD-6dw1D:undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.